Search

Your search keyword '"Soukupova, Jana"' showing total 202 results

Search Constraints

Start Over You searched for: Author "Soukupova, Jana" Remove constraint Author: "Soukupova, Jana"
202 results on '"Soukupova, Jana"'

Search Results

1. A comprehensive analysis of germline predisposition to early-onset ovarian cancer

2. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

4. A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition

6. Germline pathogenic variants in the MRE11, RAD50, and NBN (MRN) genes in cancer predisposition: A systematic review and meta‐analysis.

7. Population‐specific validation and comparison of the performance of 77‐ and 313‐variant polygenic risk scores for breast cancer risk prediction

9. A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.

12. Figure 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

13. Figure 3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

14. Figure 6 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

15. Table S2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

16. Data from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

17. Figure 4 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

18. Supplementary Methods 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

19. Figure 2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

20. Figure 5 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

21. Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?

23. Factors Influencing Farm-Land Value in the Czech Republic

25. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

26. ENIGMA CHEK2gether Project:A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

33. Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma

34. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

35. Silver Voyage from Macro- to Nanoworld

36. Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients

38. Re: ERCC3, a new ovarian cancer susceptibility gene?

39. CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate

43. Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes

44. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

45. The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases

47. Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer

48. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

50. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes

Catalog

Books, media, physical & digital resources